Category: BA.2.12.1
WHO: BA.5 now dominant globally
As of epidemiological week 24, BA.5 represents 43% of global sequences at Gisaid, BA.2 represents 25%, BA.4 represents 12%, and BA.2.12.1 represents 11%. More...
Preprint: BA.2.12.1, BA.4, and BA.5 substantially escape neutralizing antibodies
These data show that the BA.2.12.1, BA.4, and BA.5 subvariants substantially escape neutralizing antibodies induced by both vaccination and infection. More...
Germany: BA.5 now dominant with 50% of sequences
RKI: “The proportion of the omicron subline BA.5 was 50% in week 23, it has become the dominant variant. More...
Denmark: BA.5 now dominant with nearly 60% of sequences
Denmark’s latest Covid-19 report is out, and it shows another big increase in the BA.5 variant, which is now dominant in the country with nearly 60% of all sequences. More...
Denmark: BA.5 set to outcompete BA.2 this week
Denmark’s latest Covid-19 weekly trends report has just been published, and it shows a big increase in BA.5 infections over the past week. More...
Denmark: Risk assessment for SARS-CoV-2 Omicron subvariants BA.5, BA.2.12.1 and BA.4
The sub-variants provisionally amount to 21% (BA.5) and 12.4% (BA.2.12.1) per June 8 2022. More...
Denmark: BA.5 sequences up by 6.5% in one week
The latest SARS-CoV-2 sequencing figures from Denmark show a marked increase for Omicron subvariant BA.5 (shown in red), which is up by 6.54% in one week, from 10.34% to 16.88%. More...
Denmark: BA.5 up 135% in a month
The latest weekly epidemiological file for Denmark has just been published. More...
USA: BA.2.12.1 is now the dominant Covid variant at 58% of sequences
The CDC has just updated its Covid variant tracker, and it shows that the BA.2.12.1 Omicron subvariant has outcompeted BA.2, and is the dominant variant in the US, having been found in 57.9% of genome sequences. More...
Preprint: Enhanced Fusogenicity of BA.4, BA.5 and BA.2.12.1
“We found that the new Omicron subvariants BA.4/5 and BA.2.12.1 were more resistant to neutralization by mRNA-vaccinated and boosted health care worker sera and Omicron-BA.1-wave patient sera than were the BA.1 and BA.2 variants.” More...